Skip to main content

Table 2 Hemodialysis patients’ demographic profiles, hemodialysis backgrounds, levofloxacin concentrations, and protein binding ratios

From: No effect of protein binding ratio of levofloxacin in hemodialysis patients

Patient no. Age (years) Sex DW (kg) SAr (m2) DM BFR (mL/min) TT (h) BST (h) SP (g/dL) SA (g/dL) SG (g/dL) LVFX (mg/L) PBR (%)
1 52 Male 96.0 2.2 PS 250 5 Just before HD 6.9 3.9 3.0 4.0 30.9
2 88 Male 48.7 0.9 CTA 160 3 Just before HD 6.0 3.6 3.9 34.5
3 82 Male 51.5 1.1 PES 160 4 Non-HD days 5.0 2.8 2.2 7.6 29.6
4 62 Male 64.0 1.9 PES 220 4 Just before HD 6.4 3.2 3.1 1.9 20.0
5 91 Male 47.5 1.1 PES 180 4 Just before HD 6.5 2.7 3.6 7.3 23.7
6 77 Male 55.8 1.9 PES 200 4 Non-HD days 6.4 3.9 2.5 6.5 36.8
Average 75.3   60.6 1.5   195.0 4.0   6.2 3.4 2.9 5.2 29.3
SD 15.3   18.4 0.5   35.6 0.6   0.7 0.5 0.5 2.3 6.4
  1. SD standard deviation, DW dry weight, SAr surface area, DM dialyzer membrane, BFR blood flow rate, TT treatment time, BST blood sampling time after administration of levofloxacin, SP serum protein, SA serum albumin, SG serum globulin, LVFX serum levofloxacin concentration, PBR protein binding ratio, HD hemodialysis, PS polysulfone, CTA cellulose triacetate, PES polyether sulfone